Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

A New Diversity Strategy to Increase Latinx Representation in Otolaryngology: A Survey of Latinx Medical Students
Ochoa, Pablo , Vallecillo, Tissiana , O’Byrne, Jamie, Stokken, Janalee K., Ochoa, Pablo C , Vallecillo, Tissiana , O'Byrne, Jamie, Bayan, Semirra L. , Alonso, Ana Ibis Calderon, Yin, Linda X.

Hispanic Health Care International | July 10, 2025 | Volume: 24 | Issue: 1 | Pages: 55-58

10.1177/15404153251356589 | PMID 40635503 Get It

Introduction: Despite ongoing diversity initiatives, Otolaryngology – Head and Neck surgery continues to face a widening representation gap as the Latinx population in the United States grows. To address this disparity, novel strategies for recruiting Latinx medical students into the specialty must be explored. Methods: A descriptive, cross-sectional survey was distributed to Latinx medical students in the United States via social media platforms (Facebook, Twitter, Instagram) and Latino Medical Student Association (LMSA) chapters. Results: Most respondents were unfamiliar with Otolaryngology-specific health disparities affecting Latinx communities and indicated an interest in learning more about these disparities. Most respondents indicated that early exposure to Otolaryngology disparities affecting Latinx communities could increase interest in exploring the specialty. Additionally, most participants deemed a department's commitment to diversity, equity and inclusion and opportunities to serve Latinx patients to be necessary residency program attributes when deciding between programs (69.2% and 66.7%, respectively). Conclusion: Integrating community outreach and education on Otolaryngology-related health disparities into undergraduate medical education may serve as a promising strategy to enhance Latinx recruitment and representation in the specialty.
Postoperative Opioid Prescribing Following Cleft Lip Repair in 1497 Patients
Gharavi, Aidin , Srikumar, Jainaha K. , Haile, Dawit T. , Polites, Stephanie F. , Bite, Uldis, Cofer, Shelagh A. , Gibreel, Waleed , Haile, Dawit, Gibreel, Waleed , Gharavi, Aidin , Habermann, Elizabeth B. , Mardini, Samir

The Cleft Palate Craniofacial Journal | July 10, 2025 | Volume: 63 | Issue: 7 | Pages: 1963-1967

10.1177/10556656251357432 | PMID 40635468 Get It

Objective We sought to characterize the frequency of postoperative opioid prescriptions in patients undergoing cleft lip repair (CLR). Design The NSQIP-P 2023 database was queried to identify patients undergoing CLR using CPT codes. Univariable analysis was conducted to identify factors associated with postoperative opioid prescription. Setting A multicenter sample from 157 participating sites. Patients/participants A total of 1497 cases (1215 unilateral CLR and 282 bilateral CLR) were identified. Main outcomes/measures The postoperative outcomes of interest were whether an opioid was prescribed to a patient at discharge and what factors were independently associated with opioid prescribing at discharge. Results A total of 44.6% of patients with a mean age of 5.1 ± 1.9 months were prescribed opioids at discharge, most commonly oxycodone (76.3%). Univariable analysis identified an increase in weight (kg) (OR: 1.09, 95% CI: 1.02-1.17, P = .03), American Society of Anesthesiologists (ASA) classification (ordinal) (OR: 1.25, 95% CI: 1.06-1.47, P = .01), anesthesia time (10 min) (OR: 1.02, 95% CI: 1.01-1.04, P = .03), and age (months) (OR: 1.06, 95% CI: 1.00-1.12, P = .04) as being associated with opioid prescription at discharge. Bilateral versus unilateral CLR ( P = .49) and outpatient versus inpatient operation ( P = .38) were not associated with opioid prescribing. Conclusion Opioid stewardship is important in pediatric care, with our results showing age, weight, anesthesia time, and ASA classifications are predictors of opioid prescription. Further research examining contributors to patient pain following CLR is necessary to optimize opioid prescribing without negatively impacting the patient.
Procedural Characteristics and Outcomes of Transvenous Cardiac Device Extraction in Patients With Left Ventricular Assist Devices
Deering, Thomas F. , Bhimani, Ashish A. , Cole, Robert C., Kella, Danesh K , Kella, Danesh , Cole, Robert C., Goyal, Sandeep

Journal of Cardiovascular Electrophysiology | July 10, 2025 | Volume: 36 | Issue: 9 | Pages: 2160-2164

10.1111/jce.16769 | PMID 40635399 Get It

ABSTRACTIntroductionDurable left ventricular assist devices (LVADs) are susceptible to infection. The presence of a transvenous cardiac implantable electronic device (CIED) may further elevate this risk, making it necessary to remove the CIED system. This report presents the procedural characteristics and outcomes of CIED system extraction in patients with LVADs.MethodsThis is a single‐center retrospective study that included patients with durable LVADs who underwent transvenous CIED extraction at our institution from 2017 to 2023.ResultsTwenty patients with LVAD (HeartMate II = 14; HeartMate III = 6) underwent CIED removal during the study period. The median age was 52.5 (IQR = 42.5–56.5) years, and 7 patients had ischemic cardiomyopathy. Ninety percent (n = 18) of the extractions were due to infection, while 10% (n = 2) were for lead management. Complete removal of all leads was accomplished in 19 patients (95%). Overall, 40 out of 45 leads were removed during 20 procedures. Simple traction was used in 8 patients and specialized extraction tools were used in 12 (laser sheaths = 10; mechanical rotational sheaths = 7; both = 5). No leads were removed in one patient (5 leads; 2 abandoned leads with 42.5 years intravascular dwell time). There were no major procedure‐related complications. Two minor procedure‐related complications included a femoral arterial pseudoaneurysm and one pocket revision due to persistent surgical site bleeding. During a median follow‐up of 17 (IQR = 8.0–22.3) months, 8 patients underwent pump exchange due to persistent infection, and 15 remained on chronic suppressive antibiotics. Nine patients died during the follow‐up.ConclusionThe extraction of CIED systems in patients with LVAD is safe and feasible, exhibiting low procedure‐related morbidity and mortality. However, the long‐term prognosis for these patients remains poor despite the removal of CIEDs.
Deciphering the Glycoproteomic Landscape of Mood Disorders: Unveiling Molecular Association Between CDG and Depression Resilience
Preston, Graeme , Turecki, Gustavo , Frye, Mark A. , Pandey, Akhilesh , Preston, Graeme , Turecki, Gustavo , Frye, Mark , Pandey, Akhilesh , Kozicz, Tamás , Budhraja, Rohit , Joshi, Neha , Muffels, Irena , Veldić, Marin , Morava, Éva

No container title available | July 10, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-6882753/v1 | PMID 40671800 Get It

Abstract The lack of a molecular understanding of mood disorders has impeded progress in diagnosis and treatment. Glycosylation may provide insights into the complex mechanisms underlying these conditions. We conducted N-glycoproteomic analysis on dorsolateral prefrontal cortex samples from individuals with major depressive disorder (MDD) and bipolar disorder (BD), in depressive or manic states at death. Additionally, we examined depression prevalence in congenital disorders of glycosylation (CDG) through a literature review and assessment of 110 CDG patients. Glycoproteomic analysis revealed a significant increase in protein glycosylation in individuals with MDD relative to both controls and individuals with BD. Depression prevalence was lower in our pediatric and adult cohort of individuals with CDG. These results suggest brain glycosylation changes may play a role in mood disorder pathology and highlight the distinct biology of unipolar and bipolar depression. Our findings propose that impaired glycosylation may confer resilience to depression, offering potential therapeutic insights.
Chronic megacolon in a patient with Alport syndrome with diffuse leiomyomatosis
Camilleri, Michael , Damianos, John , Matkowskyj, Kristina A.

Frontline Gastroenterology | July 9, 2025 | Volume: 17 | Issue: 3 | Pages: 282-284

10.1136/flgastro-2025-103249 Get It

A 32-year-old woman with Alport syndrome and prior history of diffuse leiomyomatosis of the oesophagus and bronchial tree presented with severe constipation. MRI revealed extensive leiomyomatosis of the anorectum with obstructed defecation. Colonic manometry showed megacolon, and the patient underwent total colectomy. Surgical pathology confirmed leiomyomatosis and neuronal loss in the anorectum and reduced enteric ganglion cells in the colon. Prior literature suggests obstruction-induced enteric neuropathy as a potential mechanism for megacolon. This report shows that Alport syndrome with diffuse leiomyomatosis may have other gastrointestinal involvement including megacolon in affected patients presenting with constipation.
Type 1 Diabetes Autoantibodies in Acute, Recurrent Acute, and Chronic Pancreatitis
Wasserfall, Clive , Forsmark, Chris E. , Li, Liang , Hart, Phil A. , Goodarzi, Mark O. , Kudva, Yogish C. , Yadav, Dhiraj , Conwell, Darwin L. , Andersen, Dana K. , Casu, Anna , Cusi, Ken, Fogel, Evan L. , Park, Walter G. , Wasserfall, Clive H , Li, Shuang , Bellin, Melena D. , Conwell, Darwin L. , Serrano, Jose, Fisher, William P. , Hughes, Steven J. , Van Den Eeden, Stephen K

Diabetes | July 9, 2025 | Volume: 74 | Issue: 9 | Pages: 1603-1612

10.2337/db24-0931 | PMID 40633067 Get It

Pancreatogenic or type 3c diabetes, which occurs as a consequence of pancreatitis, may have several mechanisms. Mechanisms overlapping with those of type 2 diabetes have been explored, including insulin resistance and insulin deficiency. However, autoimmune mechanisms in response to unmasking β-cell antigens, similar to those of type 1 diabetes (T1D), have not been thoroughly examined. We performed cross-sectional T1D autoantibody profiling in a large prospective cohort (N = 927) of adults with acute, recurrent acute, or chronic pancreatitis. We examined correlations of prevalence of autoantibodies against GAD (GAD antibody), IA-2 (IA-2 antibody), zinc transporter 8 (ZnT8; ZnT8 antibody), and insulin (insulin autoantibody [IAA]) with clinical and demographic features, including presence of diabetes, diabetes treatment, and family history of diabetes. Diabetes was present in 11 (12%) of 94 participants with acute pancreatitis, 69 (27%) of 273 with recurrent acute pancreatitis, and 235 (43%) of 560 with chronic pancreatitis. Among these groups, islet autoantibodies were respectively found in five (5.3%) of 94, 48 (17.6%) of 273, and 127 (22.6%) of 560. The proportions of individuals with diabetes who were autoantibody positive were 45%, 70%, and 54%, respectively (most commonly IAA, which may reflect exogenous insulin use). However, across the entire cohort, 27 participants (2.9%) had two, two (0.2%) had three, and one (0.1%) had four T1D-associated autoantibodies, respectively, suggesting a potential pathogenic link that should be further explored. ARTICLE HIGHLIGHTS Type 1 diabetes–associated autoimmune mechanisms have not been thoroughly examined in pancreatitis-associated diabetes. We assessed the prevalence of four islet autoantibodies in serum from a large prospective cohort of patients with acute, recurrent acute, or chronic pancreatitis. Diabetes was present in 11 (12%) of 94 participants with acute pancreatitis, 69 (27%) of 273 with recurrent acute pancreatitis, and 235 (43%) of 560 with chronic pancreatitis. Excluding those with only insulin autoantibody positivity, which is confounded by insulin treatment, islet autoantibodies were identified in 51 (5.5%) of 927 participants, and 30 (3.2%) of 297 were positive for two or more autoantibodies. Our findings suggest pancreatitis may elicit islet autoimmunity in a subset of patients, necessitating prospective longitudinal follow-up.
Response to Biologics in Patients With Early-Onset Treatment-Naïve Metastatic Colorectal Cancer—An Aide et Recherche en Cancérologie Digestive Database Analysis
Jin, Zhaohui , Hubbard, Joleen M. , Eng, Cathy , Lieu, Christopher H. , Douillard, Jean‐Yves , Adams, Richard , Maughan, Tim , Cutsem, Eric Van , Venook, Alan P. , Lenz, Heinz‐Josef , Heinemann, Volker , Schmoll, H.J.E-V., Fuchs, Charles S. , Hecht, J. Randolph , Punt, Cornelis J. A. , Bokemeyer, Carsten , Gramont, Aimery de , Venook, Alan P , Maughan, Timothy S , Hubbard, Joleen , Adams, Richard , Van Cutsem, Eric , Lieu, Christopher , Jin, Zhaohui , Eng, Cathy , Dixon, Jesse G. , Stintzing, Sebastian , Saltz, Leonard B. , Falcone, Alfredo , Díaz‐Rubio, Eduardo , Punt, Cornelis J.A. , Tebbutt, Niall C. , Chibaudel, Benoist , Zalcberg, John , Yoshino, Takayuki , Shi, Qian

JCO Oncology Advances | July 9, 2025 | Volume: No volume available | Issue: 2 | Pages: No page available

10.1200/oa-24-00080 Get It

PURPOSE Colorectal cancer (CRC) incidence and mortality have decreased since the 1970s, but the incidence in young adults (<50 years, named early-onset CRC [eoCRC]) has been increasing. PATIENTS AND METHODS Individual patient data on 13,365 patients with metastatic CRC enrolled between 2000 and 2012 in 17 first-line randomized trials in the Aide et Recherche en Cancérologie Digestive database were pooled. The distribution of demographics, clinicopathologic features, biomarkers, and outcome data were summarized and compared by age groups. Progression-free survival (PFS) and overall survival (OS) were assessed by Kaplan-Meier curves and Cox models stratified by treatment arms within studies, adjusting for potential confounders. Predictive value of age group on clinical outcomes was evaluated by testing interaction effect between treatment and age variables. RESULTS Overall, 2,045 patients with eoCRC (median age, 42.5) and 11,320 patients with average-onset CRC (aoCRC; median age, 63.8) were included in this analysis. Within the eoCRC population, treatment with bevacizumab in addition to chemotherapy improved PFS (9.9 v 6.8 months; hazard ratio [HR], 0.66 [95% CI, 0.54 to 0.80]; P < .0001), which was similar to the findings in aoCRC population (9.4 v 7.3 months; HR, 0.73 [95% CI, 0.67 to 0.80]; P < .001; interaction P = .5415). However, epithelial growth factor receptor inhibitor (EGFRi) did not improve PFS in RAS wild-type (WT) patients with eoCRC who had left-sided primary tumors (8.3 v 8.9 months; HR, 1.20 [95% CI, 0.81 to 1.77]; P = .36), whereas EGFRi significantly improved PFS in the aoCRC population (9.9 v 8.5 months; HR, 0.74 [95% CI, 0.64 to 0.86]; P < .0001; interaction P = .083). CONCLUSION Treatment-naïve patients with metastatic eoCRC appear to derive similar benefit from bevacizumab as patients with aoCRC. However, patients with eoCRC with left-sided RAS/RAF WT tumors did not appear to derive benefit from first-line EGFRi.
Emerging pharmacological strategies in lipoprotein(a) reduction
Mansoor, Taha , Parikh, Sachin , Nambi, Vijay , Jia, Xiaoming , Ismayl, Mahmoud , Virani, Salim S. , Mehta, Anurag , Minhas, Abdul Mannan Khan

Baylor University Medical Center Proceedings | July 9, 2025 | Volume: 38 | Issue: 5 | Pages: 783-786

10.1080/08998280.2025.2524791 | PMID 40821459 Get It

Effect of pretreatment opioids on hemodynamics during emergency intubations: a systematic review
Hellmann, Rafael von , Maia, Ian Ward Abdalla , Driver, Brian E. , Carvalho, Julia M. Dorn De, Gerberi, Dana , Bellolio, Fernanda , Silva, L.O.J. e, Gerberi, Danielle, Oliveira J E Silva, Lucas , Bellolio, M Fernanda , Carvalho, Julia M. Dorn De

European Journal of Emergency Medicine | July 9, 2025 | Volume: 32 | Issue: 6 | Pages: 405-413

10.1097/mej.0000000000001259 | PMID 40632902 Get It

Background and importance Rapid sequence intubation in emergency settings may involve opioid pretreatment to blunt hemodynamic responses during laryngoscopy and intubation; however, opioids may lead to postintubation hypotension, increasing morbidity and mortality. Global clinical practice varies significantly, reflecting uncertainty about opioids’ benefits and risks. Objective Our goal was to evaluate the association between opioid pretreatment and hemodynamic instability, focusing on postintubation hypotension in adult patients undergoing emergency intubation. Design, settings, and participants We performed a systematic review of randomized controlled trials and observational studies comparing opioid administration vs. no opioids before adult emergency intubations. Searches included Cochrane, Embase, Medline, Scopus, and Web of Science databases until November 2024. Elective intubations were excluded. Eight (6708 patients) studies met criteria. Outcomes measure and analysis The primary outcome was postintubation hypotension, variably defined across studies. Secondary outcomes included hypoxemia, first-attempt success, cardiac arrest, and vasopressor use. Independent reviewers conducted data extraction, risk-of-bias assessments, and certainty evaluation. Results were qualitatively synthesized. Main results Among 6708 (2757 opioids and 3951 controls) patients, postintubation hypotension incidence varied widely (risk differences: −12.5% favoring opioids to +13.2% favoring controls). The single low-risk randomized study reported opioids increased hypotension (risk difference: 13%, odds ratio: 2.15, 95% confidence interval: 1.22–3.78). Observational studies yielded inconsistent results. Secondary outcomes showed no consistent differences. Evidence certainty was very low because of risk of bias, inconsistency, and imprecision. Conclusions Current evidence regarding opioid pretreatment effect on postintubation hypotension risk during emergency intubation is limited and conflicting.
Improving compliance and revenue integrity in medication billing waste documentation: A quality improvement initiative
Perna, Jessica A, Mistri, Amish, Qaderi, Misk S Al, Al Qaderi, Misk S, Shah, Vishal S, Shah, Vishal

American Journal of Health-System Pharmacy | July 9, 2025 | Volume: 83 | Issue: 4 | Pages: 196-203

10.1093/ajhp/zxaf163 | PMID 40632908 Get It

Abstract Purpose The objective of this quality improvement process was to identify quality gaps in compliance with regulatory requirements and reduce the loss of revenue resulting from noncompliance with documentation of single-dose vial waste. Methods This quality improvement initiative employed process mapping and quality gap identification to address challenges related to compliance and revenue generation. A fishbone diagram and the 5 whys technique were used to identify and analyze the root causes of missed waste documentation and workflow inconsistencies. These root causes were categorized into key areas: missing documentation, divergent workflows, inconsistencies, insufficient surveillance, and staffing issues. Leveraging these insights, we developed comprehensive educational resources such as quick reference guides and updated on-the-job training materials for the pharmacy department. Additionally, reliable, reproducible reports were created to monitor waste documentation, facilitating timely interventions whereby technicians were contacted to complete missing documentation within the 96-hour charge capture window. Results This study evaluated a total of 5,801 orders placed from October 1, 2022, to March 31, 2023, for the preimplementation period. Of these 5,801 orders, 803 (13.8%) were missing waste documentation, resulting in a total revenue loss of $362,594 when converted to the average sales price (ASP). For the postimplementation period from April 1 to September 30, 2023, a total of 10,464 orders were inspected for missing waste documentation. Only 181 orders (1.7%) were found to have incomplete waste documentation, resulting in a total revenue loss of $44,343 when converted to ASP. The postimplementation period yielded a revenue capture of $318,250, representing significant improvement in compliance with waste documentation. Conclusion This quality improvement initiative significantly reduced revenue loss from noncompliance with waste documentation for compounded sterile products. Comprehensive education and reliable reporting increased adherence to waste documentation workflows and regulatory compliance.